Dimensional Fund Advisors’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-454,213
| Closed | -$13.5M | – | 3455 |
|
|
2023
Q4 | $13.5M | Sell |
454,213
-726,531
| -62% | -$14.5M | ﹤0.01% | 2185 |
|
|
2023
Q3 | $18.7M | Sell |
1,180,744
-8,475
| -0.7% | -$141K | 0.01% | 1957 |
|
|
2023
Q2 | $22.4M | Sell |
1,189,219
-2,578
| -0.2% | -$30.4K | 0.01% | 1874 |
|
|
2023
Q1 | $4.58M | Sell |
1,191,797
-1,212,259
| -50% | -$5.17M | ﹤0.01% | 2508 |
|
|
2022
Q4 | $11.9K | Sell |
2,404,056
-136,795
| -5% | -$742K | ﹤0.01% | 2118 |
|
|
2022
Q3 | $12.1M | Buy |
2,540,851
+929,775
| +58% | +$4.9M | ﹤0.01% | 2083 |
|
|
2022
Q2 | $7.25M | Buy |
+1,611,076
| New | +$7M | ﹤0.01% | 2332 |
|
|
2022
Q1 | – | Sell |
-20,517
| Closed | -$152K | – | 3576 |
|
|
2021
Q4 | $152K | Sell |
20,517
-102,709
| -83% | -$638K | ﹤0.01% | 3384 |
|
|
2021
Q3 | $699K | Sell |
123,226
-406,595
| -77% | -$2.35M | ﹤0.01% | 3120 |
|
|
2021
Q2 | $3.49M | Buy |
+529,821
| New | +$3.7M | ﹤0.01% | 2711 |
|
|
2015
Q1 | – | Sell |
-1,100
| Closed | -$7K | – | 3405 |
|
|
2014
Q4 | $7K | Hold |
1,100
| – | – | ﹤0.01% | 3467 |
|
|
2014
Q3 | $12K | Hold |
1,100
| – | – | ﹤0.01% | 3472 |
|
|
2014
Q2 | $13K | Hold |
1,100
| – | – | ﹤0.01% | 3521 |
|
|
2014
Q1 | $16K | Sell |
1,100
-150
| -12% | -$2.37K | ﹤0.01% | 3517 |
|
|
2013
Q4 | $18K | Hold |
1,250
| – | – | ﹤0.01% | 3474 |
|
|
2013
Q3 | $21K | Sell |
1,250
-300
| -19% | -$5.27K | ﹤0.01% | 3498 |
|
|
2013
Q2 | $26K | Buy |
+1,550
| New | +$25.1K | ﹤0.01% | 3480 |
|
Other funds holding IMGN
Dimensional Fund Advisors's IMGN Position: Q1 2024 in Review
Dimensional Fund Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 454,213 shares — an estimated $13.5M sold.
Dimensional Fund Advisors first reported a position in IMGN in Q2 2013 and held it in 17 quarters. The position peaked at $22.4M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Dimensional Fund Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- Dimensional Fund Advisors sold 454,213 Immunogen Inc shares in Q1 2024, an estimated $13.5M.
- Dimensional Fund Advisors first reported a position in Immunogen Inc in Q2 2013 and held it in 17 quarters.
- Dimensional Fund Advisors's Immunogen Inc position peaked at $22.4M in Q2 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.